Cardiff Oncology, Inc. (CRDF) vs Equillium, Inc. (EQ)
A side-by-side comparison of Cardiff Oncology, Inc. and Equillium, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRDF
Cardiff Oncology, Inc.
$1.14HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
EQ
Equillium, Inc.
$1.43HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — CRDF vs EQ
growth of $100 · dividends reinvested · last 8yCRDF -78.2% (-17.3%/yr)EQ -89.6% (-24.7%/yr)CRDF compounded faster over this window
CRDF EQ
CRDF vs EQ: by the numbers
- •EQ is the larger company ($90M vs $87M market cap).
- •Both run net losses; EQ's is the smaller (0.00% vs -7884.06% net margin).
Metrics side by side
Valuation
| Metric | CRDF | EQ |
|---|---|---|
| P/S ratio | 172.20 | N/A |
| P/B ratio | 3.30 | 1.61 |
Profitability
| Metric | CRDF | EQ |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -8256.32% | 0.00% |
| Net margin | -7884.06% | 0.00% |
| ROE | -150.95% | -32.15% |
| ROIC | -159.30% | -34.10% |
Growth (annualized)
| Metric | CRDF | EQ |
|---|---|---|
| Revenue CAGR (5Y) | 5.15% | N/A |
| Total return CAGR (5Y) | -30.36% | -26.99% |
Frequently asked
- How have CRDF and EQ total returns compared?
- Over the past 5 years, CRDF delivered -30.36% and EQ delivered -26.99% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.